{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:01:15Z","timestamp":1791496875843,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1007\/s10787-997-0029-2","type":"journal-article","created":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T02:26:32Z","timestamp":1185503192000},"page":"319-329","source":"Crossref","is-referenced-by-count":9,"title":["Neurogenic inflammation in lung disease: Burnt out?"],"prefix":"10.1007","volume":"5","author":[{"given":"D. F.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.13.1.27","volume":"13","author":"MS Dunnil","year":"1960","unstructured":"Dunnil MS. The pathology of asthma with special reference to changes in the mucosa. J Clin Pathol. 1960;13:27\u201333.","journal-title":"J Clin Pathol"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(54)91030-2","volume":"i","author":"L Reid","year":"1954","unstructured":"Reid L. Pathology of chronic bronchitis. Lancet. 1954;i:275\u20138.","journal-title":"Lancet"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1113\/expphysiol.1913.sp000144","volume":"6","author":"AN Bruce","year":"1913","unstructured":"Bruce AN. Vaso-dilator axon reflexes. Q J Exp Physiol. 1913;6:339\u201354.","journal-title":"Q J Exp Physiol"},{"key":"29_CR4","first-page":"143","volume":"43","author":"P Holzer","year":"1991","unstructured":"Holzer P. Capsaicin: cellular targets, mechanism of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991;43:143\u2013201.","journal-title":"Pharmacol Rev"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0306-4522(88)90064-4","volume":"24","author":"P Holzer","year":"1988","unstructured":"Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of the tachykinins, calcitonin gene related peptide and other neuropeptides. Neuroscience. 1988;24:739\u201368.","journal-title":"Neuroscience"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-3623(88)90002-X","volume":"19","author":"CA Maggi","year":"1987","unstructured":"Maggi CA, Meli A. The sensory-efferent function of capsaicin-sensitive sensory neurones. Gen Pharmacol. 1987;19:1\u201343.","journal-title":"Gen Pharmacol"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm\/144.5.1187","volume":"144","author":"PJ Barnes","year":"1991","unstructured":"Barnes PJ, Baraniuk JN, Belvisi MG. Neurpeptides in the respiratory tract. Am Rev Respir Dis. 1991;144:1187\u201398.","journal-title":"Am Rev Respir Dis"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1474-8673.1993.tb00396.x","volume":"13","author":"CA Maggi","year":"1993","unstructured":"Maggi CA, Patacchini R, Rovero P, Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol. 1993;13:23\u201393.","journal-title":"J Auton Pharmacol"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/1357-2725(96)00017-9","volume":"28","author":"AM Khawaja","year":"1996","unstructured":"Khawaja AM, Rogers DF. Tachykinins: receptor to effector. Int J Biochem Cell Biol. 1996;28:721\u201338.","journal-title":"Int J Biochem Cell Biol"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/pulp.1994.1002","volume":"7","author":"SI Ramnarine","year":"1994","unstructured":"Ramnarine SI, Rogers DF. Non-adrenergic, non-cholinergic neural control of mucus secretion in the airways. Pulm Pharmacol. 1994;7:19\u201333.","journal-title":"Pulm Pharmacol"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-6147(96)10027-4","volume":"17","author":"C Bertrand","year":"1996","unstructured":"Bertrand C, Geppetti P. Tachykinin and kinin receptor antagonists: therapeutic perspectives in allergic disease. Trends Pharmacol Sci. 1996;17:255\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1183\/09031936.94.07061161","volume":"7","author":"GF Joos","year":"1994","unstructured":"Joos GF, Germonpr\u00e9 PR, Kips JC, Peleman RA, Pauwels RA. Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J. 1994;7:1161\u201371.","journal-title":"Eur Respir J"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/0024-3205(87)90130-5","volume":"40","author":"CR Martling","year":"1987","unstructured":"Martling CR, Theodorsson-Norheim E, Lundberg JM. Occurrence and effects of multiple tachykinins: substance P, neurokinin A, and neuropeptide K in human lower airways. Life Sci. 1987;40:1633\u201343.","journal-title":"Life Sci"},{"key":"29_CR14","first-page":"251","volume":"236","author":"JM Lundberg","year":"1984","unstructured":"Lundberg JM, Hokfelt, T, Martling CR, Saria A, Cuello C. Substance P immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res. 1984;236:251\u201361.","journal-title":"Cell Tissue Res."},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000235449","volume":"95","author":"T Komatsu","year":"1991","unstructured":"Komatsu T, Yamamoto M, Shimokata K, Nagura H. Distribution of substance P-immunoreactive and calcitonin gene-related-immunoreactive nerves in normal human lungs. Int Arch Allergy Appl Immunol. 1991;95:23\u20138.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00239446","volume":"258","author":"A Luts","year":"1989","unstructured":"Luts A, Sundler F. Peptide-containing nerve fibers in the respiratory tract of the ferret. Cell Tissue Res. 1989;258:259\u201367.","journal-title":"Cell Tissue Res"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1748-1716.1983.tb07304.x","volume":"119","author":"JM Lundberg","year":"1983","unstructured":"Lundberg JM, Martling C-R, Saria A. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand. 1983;119:49\u201353.","journal-title":"Acta Physiol Scand"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(89)92509-9","volume":"1","author":"DF Rogers","year":"1989","unstructured":"Rogers DF, Barnes PJ. Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet. 1989;1:930\u20132.","journal-title":"Lancet"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0306-4522(83)90117-3","volume":"10","author":"JM Lundberg","year":"1983","unstructured":"Lundberg JM, Martling C-R, Saria A, Folkers K, Rosell S. Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release. Neuroscience. 1983;10:1361\u20138.","journal-title":"Neuroscience"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1476-5381.1994.tb17122.x","volume":"113","author":"SI Ramnarine","year":"1994","unstructured":"Ramnarine SI, Hirayama Y, Barnes PJ, Rogers DF. \u2018Sensory-efferent\u2019 neural control of mucus secretion: characterisation using tachykinin receptor antagonists in ferret trachea in vitro. Br J Pharmacol. 1994;113:1183\u201390.","journal-title":"Br J Pharmacol"},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1113\/jphysiol.1985.sp015773","volume":"365","author":"B Baker","year":"1985","unstructured":"Baker B, Peatfield AC, Richardson PS. Nervous control of mucin secretion into human bronchi. J Physiol. 1985;365:297\u2013305.","journal-title":"J Physiol"},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1165\/ajrcmb.14.4.8600937","volume":"14","author":"CR Killingsworth","year":"1996","unstructured":"Killingsworth CR, Paulauskis JD, Shore S. Substance P content and preprotachykinin gene-ImRNA expression in a rat model of chronic bronchitis. Am J Respir Cell Mol Biol. 1996;14:334\u201340.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1748-1716.1991.tb09105.x","volume":"141","author":"J-A Karlsson","year":"1991","unstructured":"Karlsson J-A, Zackrisson C, Lundberg JM. Hyperresponsiveness to tussive stimuli in cigarette smoke-exposed guinea-pigs: a role for capsacin-sensitive, calcitonin gene-related peptide-containing nerves. Acta Physiol Scand. 1991;141:445\u201354.","journal-title":"Acta Physiol Scand"},{"key":"29_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1164\/ajrccm.153.1.8542109","volume":"153","author":"E Balzamo","year":"1996","unstructured":"Balzamo E, Joanny P, Steinberg JG, Oliver C, Jammes Y. Mechanical ventilation increases substance P concentration in the vagus, sympathetic, and phrenic nerves. Am J Respir Crit Care Med. 1996;153:153\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"29_CR25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(86)90777-4","volume":"i","author":"PJ Barnes","year":"1986","unstructured":"Barnes PJ. Asthma as an axon reflex. Lancet. 1986;i:242\u20135.","journal-title":"Lancet"},{"key":"29_CR26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/pulp.1995.1028","volume":"8","author":"AJ Fox","year":"1995","unstructured":"Fox AJ. Mechanisms and modulation of capsaicin activity on airway afferent nerves. Pulm Pharmacol. 1995;8:207\u201315.","journal-title":"Pulm Pharmacol"},{"key":"29_CR27","first-page":"69","volume":"108","author":"H-P Kuo","year":"1992","unstructured":"Kuo H-P, Rohde JAL, Barnes PJ, Rogers DF. Cigarette smoke-induced airway goblet cell secretion: dose-dependent differential nerve activation. Am J Physiol. 1992;108:69\u201376.","journal-title":"Am J Physiol."},{"key":"29_CR28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/thx.48.4.396","volume":"48","author":"J-A Karlsson","year":"1993","unstructured":"Karlsson J-A. A role for capsaicin sensitive, tachykinin containing nerves in chronic coughing and sneezing but not in asthma: a hypothesis. Thorax. 1993;48:396\u2013400.","journal-title":"Thorax"},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/01902149209031686","volume":"18","author":"AR Burns","year":"1992","unstructured":"Burns AR, James AL, Greene SG, Schellenberg RR, Hogg JC. Effect of airways sensory C fibre network degeneration on airways permeability and responsiveness. Exp Lung Res. 1992;18:287\u201398.","journal-title":"Exp Lung Res"},{"key":"29_CR30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nm0796-814","volume":"7","author":"AJ Fox","year":"1996","unstructured":"Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin-evoked sensitisation of airway sensory nerves: a mechanisms for ACE-inhibitor cough. Nature Med. 1996;7:814\u20137.","journal-title":"Nature Med"},{"key":"29_CR31","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1183\/09031936.94.07122169","volume":"7","author":"LO Cardell","year":"1994","unstructured":"Cardell LO, Uddman R, Edvisson L. Low plasma levels of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J. 1994;7:2169\u201373.","journal-title":"Eur Respir J"},{"key":"29_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1164\/ajrccm\/151.3_Pt_1.613","volume":"151","author":"M Tomaki","year":"1995","unstructured":"Tomaki M, Ichinose M, Miura M et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care med. 1995;151:613\u20137.","journal-title":"Am J Respir Crit Care med"},{"key":"29_CR33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0091-6749(92)90138-R","volume":"90","author":"K Nieber","year":"1992","unstructured":"Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and \u03b2-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol. 1992;90:646\u201352.","journal-title":"J Allergy Clin Immunol"},{"key":"29_CR34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1164\/ajrccm.151.2.7531100","volume":"151","author":"CM Lilly","year":"1995","unstructured":"Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content from asthmatic and nonasthmatic patients. Am J Crit Care Med. 1995;151:548\u201353.","journal-title":"Am J Crit Care Med"},{"key":"29_CR35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1183\/09031936.93.04060673","volume":"4","author":"SL Ollerenshaw","year":"1991","unstructured":"Ollerenshaw SL, Javis D, Woolcock A, Sullivan C, Scheibner T. Substance P immunoreactive nerves in airways from asthmatics and non-asthmatics. Eur Respir J. 1991;4:673\u201382.","journal-title":"Eur Respir J"},{"key":"29_CR36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1165\/ajrcmb.13.3.7654385","volume":"13","author":"PH Howarth","year":"1995","unstructured":"Howarth PH, Djukanovic R, Reddington T, Holgate ST, Springall DR, Polak JM Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and non-asthmatic subjects. Am J Respir Cell Mol Biol. 1995;13:288\u201396.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"29_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0110001","volume":"11","author":"IM Adcock","year":"1993","unstructured":"Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. Increased tachykinin recepetor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol. 1993;11:1\u20137.","journal-title":"J Mol Endocrinol"},{"key":"29_CR38","first-page":"L309","volume":"269","author":"A Bai","year":"1995","unstructured":"Bai A, Zhou D, Weir T et al. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol. 1995;269:L309\u201317.","journal-title":"Am J Physiol"},{"key":"29_CR39","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1164\/ajrccm\/141.3_Pt_2.S151","volume":"141","author":"RG Goldie","year":"1990","unstructured":"Goldie RG. Receptors in asthmatic airways. Am Rev Respir Dis. 1990;141:S151\u20136.","journal-title":"Am Rev Respir Dis"},{"key":"29_CR40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1476-5381.1992.tb14524.x","volume":"107","author":"T Fujii","year":"1992","unstructured":"Fujii T, Murai M, Morimoto H et al. Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888. Br J Pharmacol. 1992;107:785\u20139.","journal-title":"Br J Pharmacol"},{"key":"29_CR41","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1476-5381.1994.tb14892.x","volume":"111","author":"Z-Y Wang","year":"1994","unstructured":"Wang Z-Y, Tung SR, Strichartz GR, Hakanson R. Investigation of the specificity of FK888 as a tachykinin NK1 receptor antagonist. Br J Pharmacol. 1994;111:1342\u20136.","journal-title":"Br J Pharmacol"},{"key":"29_CR42","first-page":"472","volume":"267","author":"S McLean","year":"1993","unstructured":"McLean S, Ganong A, Seymour PA et al. Pharmacology of CP-99,994: a non-peptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther. 1993;267:472\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"29_CR43","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1164\/ajrccm.153.3.8630576","volume":"153","author":"M Ichinose","year":"1996","unstructured":"Ichinose M, Murai M, Yamaguchi H, et al. A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients. Am J Respir Crit Care Med. 1996;153:936\u201341.","journal-title":"Am J Respir Crit Care Med"},{"key":"29_CR44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1164\/ajrccm.152.3.7663799","volume":"152","author":"J Fahy","year":"1995","unstructured":"Fahy J, Wong HH, Geppetti P et al. Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am J Respir Crit Care Med. 1995;152:879\u201384.","journal-title":"Am J Respir Crit Care Med"},{"key":"29_CR45","first-page":"1489","volume":"271","author":"CA Maggi","year":"1994","unstructured":"Maggi CA, Astolfi M, Guiliani S et al. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors. J Pharmacol Exp Ther. 1994;271:1489\u2013500.","journal-title":"J Pharmacol Exp Ther"},{"key":"29_CR46","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1164\/ajrccm\/146.5_Pt_1.1177","volume":"146","author":"C Advenier","year":"1992","unstructured":"Advenier C, Naline E, Toty L et al. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist on the neurokinin A (NK2) receptors. Am Rev Respir Dis. 1992;146:1177\u201381.","journal-title":"Am Rev Respir Dis"},{"key":"29_CR47","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1164\/ajrccm.153.5.8630592","volume":"153","author":"V Girard","year":"1996","unstructured":"Girard V, Yavo JC, Emonds-Alt X, Advenier C. The tachykinin NK2 receptor antagonist SR 48968 inhibits citric acid-induced airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med. 1996;153:1496\u2013502.","journal-title":"Am J Respir Crit Care Med"},{"key":"29_CR48","first-page":"398","volume":"262","author":"H Morimoto","year":"1992","unstructured":"Morimoto H, Murai M, Maeda Y et al. FK224, a noval cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivty. J Pharmacol Exp Ther. 1992;262:398\u2013402.","journal-title":"J Pharmacol Exp Ther"},{"key":"29_CR49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1476-5381.1993.tb12888.x","volume":"108","author":"Y Hirayama","year":"1993","unstructured":"Hirayama Y, Lei Y-H, Barnes PJ, Rogers DF. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo. Br J Pharmacol. 1993;108:844\u201351.","journal-title":"Br J Pharmacol"},{"key":"29_CR50","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0140-6736(92)92948-F","volume":"340","author":"M Ichinose","year":"1993","unstructured":"Ichinose M, Nakajima N, Takahashi T, Yamaguchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet. 1993;340:1248\u201351.","journal-title":"Lancet"},{"issue":"Suppl","key":"29_CR51","first-page":"A318","volume":"147","author":"M Ichinose","year":"1993","unstructured":"Ichinose M, Katsumata U, Kikuchi R et al. Effect of tachykinin antagonist on chronic bronchitis patients. Am Rev Respir Dis. 1993;147(Suppl):A318.","journal-title":"Am Rev Respir Dis"},{"key":"29_CR52","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1164\/ajrccm.153.6.8665034","volume":"153","author":"GF Joos","year":"1996","unstructured":"Joos GF, van Schoor J, Kips JC, Pauwels R. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction. Am J Respir Crit Care Med. 1996;153:1781\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"29_CR53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-6147(90)90112-L","volume":"11","author":"PJ Barnes","year":"1990","unstructured":"Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol Sci. 1990;11:185\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"29_CR54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2222.1994.tb00211.x","volume":"24","author":"I Pavord","year":"1994","unstructured":"Pavord I, Hall I, Wahedna I, Cooper S, Tattersfield A. Effect of 443c81, an inhaled \u03bc-opioid receptor agonist in asthma. Clin Exp Allergy. 1994;24:144\u20138.","journal-title":"Clin Exp Allergy"},{"key":"29_CR55","doi-asserted-by":"crossref","first-page":"L278","DOI":"10.1152\/ajpcell.1995.268.1.C278","volume":"268","author":"NK Harrison","year":"1995","unstructured":"Harrison NK, Dawes KE, Kwon O-J, Barnes PJ, Laurent GJ, Chung KF. Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am J Physiol. 1995;268:L278\u201383.","journal-title":"Am J Physiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-997-0029-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-997-0029-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-997-0029-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T15:41:31Z","timestamp":1683992491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-997-0029-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s10787-997-0029-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}